- Economy
- Education And Career
- Companies & Markets
- Gadgets & Technology
- After Hours
- Healthcare
- Banking & Finance
- Entrepreneurship
- Energy & Infra
- Case Study
- Video
- More
- Sustainability
- Web Exclusive
- Opinion
- Luxury
- Legal
- Property Review
- Cloud
- Blockchain
- Workplace
- Collaboration
- Developer
- Digital India
- Infrastructure
- Work Life Balance
- Test category by sumit
- Sports
- National
- World
- Entertainment
- Lifestyle
- Science
- Health
- Tech
Latest Articles in Moderna
Moderna Covid Vaccine Produces Lasting Immune Response, Study Finds
They found that the Moderna vaccine spurs an adaptive immune response to the SARS-CoV-2 spike protein nearly identical to the immune system's response to a natural infection.
Read More
Moderna, Japan Partner Recall 1.6 Million Doses
The companies on Aug. 26 announced suspension of 1.63 million doses produced at the line after reports of contamination.
Read More
Japan Suspends 1.63M Doses Of Moderna Over Contamination
The health ministry said contamination was reported from multiple vaccination sites. Some doses might have been administered, but no adverse health effects have been reported so far
Read More
No Sign Of Pfizer, Moderna Covid Vaccines In Breast Milk: Study
The researchers at University of California, San Francisco (USCF) in the US analysed the breast milk of seven women after they received the Pfizer and Moderna mRNA vaccines, and found no trace of the preventives.
Read More
India Offered 7.5 Mn Doses Of Moderna Vaccine; No Consensus On Indemnity Clause Yet: Sources
NITI Aayog member (Health) Dr V K Paul had recently said the government is working actively with Moderna to see how its vaccine can be imported and made available in the country.
Read More
Cases Of Lambda Covid-19 Variant Found In Canada
The Public Health Agency of Canada is monitoring Lambda to see how it spreads and how it responds to vaccines,
Read More
Pfizer, Moderna Vaccines Cut Covid-19 Risk By 91%: Study
The mRNA vaccines by Pfizer and Moderna contain genetic instructions for our cells to make the spike protein of the SARS-CoV-2, which the virus uses to infect and enter the human cells.
Read More
Serum Institute Asks Govt To Take Up Inclusion Of Covishield In Vaccination Passport With EU
The letter also mentions that AstraZeneca-SII Covishield has been manufactured under technology transfer from Oxford/AstraZeneca and that clinical trials of the vaccine have been conducted successfully abroad and has been approved by MHRA for emergency use approval.
Read More
Canada: Pfizer, Moderna Preferred 2nd Dose After AstraZeneca
On June 1, committee had said AstraZeneca recipients “could" get Pfizer or Moderna for their second shot if they wanted, but Thursday went further to say an mRNA vaccine was the ”preferred" choice.
Read More
VAV Lifesciences To Supply Key COVID Vaccine Ingredient To Pfizer, Moderna
The US firm will use the lipids made by VAV to produce gene-based lipid nanoparticles on behalf of the brand owners -- Pfizer-BioNTech and Moderna.
Read More
India Likely To Waive Customs Duty On COVID-19 Vaccine Imports
The government presently levies 10 per cent customs or import duty plus a 16.5 per cent I-GST and social welfare surcharge on vaccines coming from overseas
Read More
Pfizer Wants To Make Vaccine In India If Faster Clearance, Export Freedom Assured
The Serum Institute of India, the world's largest vaccine maker, is already bulk-manufacturing the Oxford University/AstraZeneca product and plans to start producing the Novavax Inc shot from next month.
Read More
AstraZeneca Has Sold Its Stake In Moderna For More Than $1 Billion
AstraZeneca is retaining partnership with Moderna on other disease treatments and could sell its AstraZeneca/Oxford University COVID-19 vaccine on a commercial basis in future if the virus becomes endemic
Read More
AstraZeneca Has Sold Its Stake In Moderna For More Than $1 billion
The report added that it was not clear over what period British-based AstraZeneca sold its holding in Moderna.
Read More
Moderna Expects $18.4 Billion In COVID-19 Vaccine Sales In 2021
Pfizer earlier this month forecast $15 billion in its share of sales from the COVID-19 vaccine it developed jointly with partner BioNTech.
Read More